Crestline Management »

United Therapeutics Corporation shares owned by Crestline Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Crestline Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $3.4M 12k 278.09
2022-09-30 $2.5M 12k 209.34
2022-06-30 $1.7M 7.1k 235.62
2022-03-31 $1.6M 8.7k 179.47
2021-12-31 $4.4M 20k 216.08
2021-09-30 $3.2M 17k 184.55
2021-06-30 $2.0M 11k 179.39
2019-09-30 $3.0M 38k 79.76
2019-06-30 $1.0M 13k 78.08

More positions owned by Crestline Management

Denali Therapeutics (DNLI)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Macy's (M)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Energy Transfer Com Ut Ltd Ptn (ET)
First Industrial Realty Trust (FR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Arcosa (ACA)
NiSource (NI)
Bausch Health Companies (BHC)
PPL Corporation (PPL)
American Intl Group Com New (AIG)
Allstate Corporation (ALL)
Algonquin Power & Utilities equs (AQN)
Sana Biotechnology (SANA)

View all positions for Crestline Management

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
Bank of New York Mellon
AQR Capital Management
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
LSV Asset Management
Charles Schwab Investment Management
Pacer Advisors
Caisse de depot et placement du Quebec
Legal & General Group

View all funds holding United Therapeutics Corporation